Published in Ann Oncol on July 01, 2000
Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer. Gynecol Oncol (2008) 1.27
The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients. Br J Cancer (2009) 1.09
Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease. Eur J Med Res (2010) 0.96
Colorectal cancer metastasis: in the surgeon's hands? Int Semin Surg Oncol (2005) 0.95
Spatially gradated segregation and recovery of circulating tumor cells from peripheral blood of cancer patients. Biomicrofluidics (2013) 0.92
Circulating tumor cells measurements in hepatocellular carcinoma. Int J Hepatol (2012) 0.91
Circulating tumor cells in gastrointestinal malignancies: current techniques and clinical implications. J Oncol (2009) 0.87
Isolation and analysis of rare cells in the blood of cancer patients using a negative depletion methodology. Methods (2013) 0.81
Tumor biology and cancer therapy - an evolving relationship. Cell Commun Signal (2009) 0.80
Accurate molecular detection of melanoma nodal metastases: an assessment of multimarker assay specificity, sensitivity, and detection rate. Mol Pathol (2003) 0.77
Circulating tumor cells in germ cell tumors: are those biomarkers of real prognostic value? A review. Clujul Med (2016) 0.75
Digital necrosis associated with chronic myeloid leukemia: a rare paraneoplastic phenomenon. Acta Clin Belg (1995) 1.95
International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury. J Clin Oncol (1999) 1.76
Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood (1998) 1.55
Parvovirus B19 and blood products. Lancet (1994) 1.44
Dose-dependent interleukin-3 stimulation of thrombopoiesis and neutropoiesis in patients with small-cell lung carcinoma before and following chemotherapy: a placebo-controlled randomized phase Ib study. J Clin Oncol (1993) 1.42
Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. Blood (1997) 1.19
Human herpes virus 6 infection is a hallmark of cord blood transplant in adults and may participate to delayed engraftment: a comparison with matched unrelated donors as stem cell source. Bone Marrow Transplant (2009) 1.09
Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU). Eur J Cancer (1999) 1.07
Resistance to cisplatin: how to deal with the problem? Eur J Cancer (1990) 1.00
Targeting retroviral vectors to CD34-expressing cells: binding to CD34 does not catalyze virus-cell fusion. Hum Gene Ther (1999) 1.00
Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study. J Clin Oncol (1987) 0.98
Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation. Leukemia (2011) 0.96
Unreliability of carcinoembryonic antigen (CEA) reverse transcriptase-polymerase chain reaction (RT-PCR) in detecting contaminating breast cancer cells in peripheral blood stem cells due to induction of CEA by growth factors. Bone Marrow Transplant (1999) 0.93
Plasmacytoid dendritic cells and Th17 immune response contribution in gastrointestinal acute graft-versus-host disease. Leukemia (2012) 0.92
Molecular analysis of a germ line-encoded idiotypic marker of pathogenic human lupus autoantibodies. J Immunol (1990) 0.92
Simultaneous study of five candidate target antigens (CD20, CD22, CD33, CD52, HER2) for antibody-based immunotherapy in B-ALL: a monocentric study of 44 cases. Leukemia (2008) 0.89
IL-3 and peripheral blood stem cell harvesting. Stem Cells (1993) 0.86
Immunodetection of small cell lung cancer metastases in bone marrow using three monoclonal antibodies. Eur J Cancer Clin Oncol (1988) 0.83
The effect of neutropenia on the cell cycle of granulocyte precursors in an in vivo culture system. Blood (1974) 0.82
Restriction fragment length polymorphisms and single germline coding region sequence in VH18/2, a duplicated gene encoding autoantibody. Mol Immunol (1993) 0.81
Biology of small cell lung cancer: an overview. Eur Respir J (1990) 0.80
Outcome after reduced-intensity conditioning allogeneic SCT for AML in first complete remission: comparison of two regimens. Bone Marrow Transplant (2008) 0.80
Leukocyte membrane proteins in chronic lymphocytic leukemia, as studied by two-dimensional gel electrophoresis. Clin Chem (1984) 0.80
Highly purified CD34+ cells isolated using magnetically activated cell selection provide rapid engraftment following high-dose chemotherapy in breast cancer patients. Bone Marrow Transplant (2000) 0.80
Recombinant interleukin-2 in metastatic renal cell carcinoma--a European multicentre phase II study. Eur J Cancer (1991) 0.80
Effects of daunorubicin and doxorubicin, free and associated with DNA, on hemopoietic stem cells. Cancer Res (1979) 0.79
[Diagnosis and treatment of CMV and EBV Reactivation as well as Post-transplant Lymphoproliferative Disorders following Allogeneic Stem Cell Transplantation: An SFGM-TC report]. Pathol Biol (Paris) (2013) 0.79
Factors predicting allogeneic PBSCs yield after G-CSF treatment in healthy donors. Bone Marrow Transplant (2009) 0.79
Identification of a light density murine megakaryocyte progenitor (LD-CFU-M). Blood (1988) 0.79
Features of EBV reactivation after reduced intensity conditioning unrelated umbilical cord blood transplantation. Bone Marrow Transplant (2011) 0.79
Interaction between protein kinase C and actin in megakaryocyte polyploidization. Anticancer Res (2000) 0.78
Prophylaxis with mycophenolate mofetil and CsA can decrease the incidence of severe acute GVHD after antithymocyte globulin-based reduced-intensity preparative regimen and allo-SCT from HLA-matched unrelated donors. Bone Marrow Transplant (2009) 0.78
Diffusion chamber colony-forming unit (CFU-d): a primitive stem cell. Int J Cell Cloning (1989) 0.78
"Spontaneous" erythroid progenitor cells in the circulation and monosomy 7 in juvenile chronic myelogenous leukemia. Cancer Genet Cytogenet (1982) 0.78
Induction and enhancement of normal human megakaryocyte polyploidization are concomitant with perturbation in the actin metabolism. Eur J Clin Invest (1998) 0.78
In vivo stimulation and inhibition of granulopoiesis: the effect of an inflammatory reaction on murine diffusion chamber granulopoiesis. Br J Haematol (1982) 0.78
Cholinergic enhancement of megakaryocytopoiesis and granulocytopoiesis in culture: mediation via T-lymphocytes. Exp Hematol (1989) 0.78
International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury. Ann Oncol (1999) 0.78
Safety and efficacy of rituximab in steroid-refractory chronic GVHD. Bone Marrow Transplant (2012) 0.78
Fetal hemopoiesis in diffusion chamber cultures. III. The effect of neutropenia. Blood (1976) 0.77
Retrovirus-mediated gene transfer of the human multidrug resistance-associated protein into hematopoietic cells protects mice from chemotherapy-induced leukopenia. Hum Gene Ther (1999) 0.77
Cytolytic response of human T cells against allogeneic small cell lung carcinoma treated with interferon gamma. Cancer Immunol Immunother (1988) 0.77
In vivo elaboration of CSF in acute inflammation: proportionality to the intensity of the inflammatory stimulus and requirement of T lymphocytes. Eur J Haematol (1990) 0.77
Oligonucleotide probes to the 5' end of the framework 3 (FR3) gene segment detect polymorphisms of VH gene sequences encoding biologically important amino acid residues. Scand J Immunol (1993) 0.77
ESTIC position paper: high-dose chemotherapy for breast cancer, investigation should continue. Ann Oncol (1999) 0.77
Cytogenetic investigations in childhood chronic myelocytic leukemia. Cancer Genet Cytogenet (1986) 0.76
Retroviral-mediated transfer of genes encoding interleukin-2 and interleukin-12 into fibroblasts increases host antitumor responsiveness. Cancer Gene Ther (1999) 0.76
Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patients. Ann Hematol (2000) 0.76
Inhibition of actin polymerization by cytochalasin B induces polyploidization and increases the number of nucleolar organizer regions in human megakaryocyte cell lines. Anticancer Res (1998) 0.76
Chemoprotection and selection by chemotherapy of multidrug resistance-associated protein-1 (MRP1) transduced cells. Curr Gene Ther (2001) 0.76
Inhibition of tubulin polymerization in megakaryocyte cell lines leads to polyploidization which affects the metabolism of actin. Anticancer Res (1998) 0.76
Anti-CD34+ Fabs generated against hematopoietic stem cells in HIV-derived combinatorial immunoglobulin library suggest antigen-selected autoantibodies. Mol Immunol (1998) 0.76
Detection of circulating tumor by reverse transcriptase polymerase chain reaction. J Clin Oncol (2000) 0.75
Surgical treatment of a foscavir-resistant atypical Cytomegalovirus pneumonia in an allogeneic stem cell transplant recipient. Haematologica (2008) 0.75
Digital necrosis associated with chronic myeloid leukemia: a rare paraneoplastic phenomenon ... and not a toxicity of recombinant interferon. Acta Clin Belg (1997) 0.75
Effect of graft source on mismatched unrelated donor hemopoietic stem cell transplantation after reduced intensity conditioning. Leukemia (2013) 0.75
Augmentation of the number of nucleolar organizer regions in human megakaryocyte cell lines after induction of polyploidization by a microtubule inhibitor. Eur J Clin Invest (1998) 0.75
Analysis of megakaryocytes by flow cytometry. Haematologia (Budap) (1998) 0.75
High-dose chemo-radiotherapy cycles for LD small cell lung cancer patients using G-CSF and blood stem cells. Bone Marrow Transplant (1996) 0.75
European School of Oncology: management of non-Hodgkin's lymphomas: conclusions of the European School of Oncology Meeting, 1986. Eur J Cancer Clin Oncol (1987) 0.75
Effect of lithium on diffusion chamber granulopoiesis. Int J Cell Cloning (1984) 0.75
In vivo induction of granulopoiesis in visceral yolk-sac cells by foetal hepatic factors. J Embryol Exp Morphol (1983) 0.75
Fetal hemopoiesis in diffusion chamber cultures. I. The pattern of pluripotent stem cell growth. Cell Tissue Kinet (1976) 0.75
Concentration of bone marrow progenitor cells by separation on a Percoll gradient using the Haemonetics model 30. Bone Marrow Transplant (1988) 0.75
Growth of stem cell concentration in diffusion chambers (DC). Cell Tissue Kinet (1974) 0.75
A phase I study of vinblastine tryptophan ester. Cancer Chemother Pharmacol (1986) 0.75
Murine yolk sac hematopoiesis studied with the diffusion chamber technique. Exp Hematol (1978) 0.75
Myeloid stem cell kinetics in children hypertransfused during remission induction of acute lymphoblastic leukemia. Blood Cells (1982) 0.75
Metastatic renal cell cancer treated with low-dose interleukin-2. A phase-II multicentre study. Cancer Treat Rev (1989) 0.75
Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumors. Exp Hematol (1992) 0.75
Peripheral blood mononuclear cells from autologous hematopoietic stem cell transplantation recipients produce and respond to IL-12. Bone Marrow Transplant (1996) 0.75
[Abnormalities in serum magnesium concentration]. Rev Med Liege (2003) 0.75
Monoclonal antibodies for the in vitro detection of small cell lung cancer metastases in human bone marrow. Eur J Cancer Clin Oncol (1988) 0.75
Severe anal condylomata acuminata following high-dose chemotherapy and autologous hematopoietic stem cell transplantation: a case report. Acta Gastroenterol Belg (1997) 0.75
Fetal hemopoiesis in diffusion chamber cultures: II. Cell proliferation and differentiation. Nouv Rev Fr Hematol (1976) 0.75
Translocation t(3;17)(q26;q22): a marker of acute disease in myeloproliferative disorders? Cancer Genet Cytogenet (1984) 0.75
In vivo stimulation and inhibition of granulopoiesis at the stem cell level. Prog Clin Biol Res (1985) 0.75
Detection of small cell lung cancer bone marrow metastases by immunofluorescence. Pathol Biol (Paris) (1988) 0.75
Detection of small cell lung cancer bone marrow metastases by tumor stem cell assay. Pathol Biol (Paris) (1988) 0.75
Quantification of CD34+ cells mobilized into the peripheral blood predicts the yield of the leukapheresis product and can replace progenitor assays. Cytokines Cell Mol Ther (1997) 0.75
The diffusion chamber technique as an in vivo assay in mice for the effectiveness of antitumor agents. Scand J Haematol (1979) 0.75
Interleukin-2 after autologous bone marrow transplantation as consolidative immunotherapy against minimal residual disease. Nouv Rev Fr Hematol (1990) 0.75
Selective hypoplasia of pelvic bone marrow. Scand J Haematol (1980) 0.75
Carboplatin in combination with etoposide in inoperable non-small-cell lung cancer (NSCLC). Med Oncol Tumor Pharmacother (1990) 0.75
Tolerance of sequential or simultaneous administration of IL-3 and G-CSF in improving peripheral blood stem cells harvesting following multi-agent chemotherapy: a pilot study. Bone Marrow Transplant (1994) 0.75
[Clinical and biological aspects of intensive chemotherapy with autologous bone marrow grafts in small-cell bronchial cancer]. Bull Mem Acad R Med Belg (1989) 0.75
Endomitotic index of megakaryocytes measured by flow cytometry helps to diagnose hematological disorders with abnormal platelet counts. Anticancer Res (1998) 0.75
Proliferative and differentiative potential of murine yolk sac and fetal stem cells. Bone Marrow Transplant (1992) 0.75
Sequential dacarbazine chemotherapy followed by recombinant interleukin-2 in metastatic melanoma. A pilot multicentre phase I-II study. Eur J Cancer Clin Oncol (1989) 0.75
[Efficiency of high-dose FEC chemotherapy for the mobilization of hematopoietic stem cells into peripheral blood]. Bull Cancer (1997) 0.75